1. United States of America Stocks

  2. •

    Consumer Cyclical

  3. •

    Specialty Retail
Meso Numismatics, Inc.

Meso Numismatics, Inc.

MSSV
Meso Numismatics, Inc.US flagOther OTC
0.03
USD
+0.00
- -
326,014.00Market Cap
Meso Numismatics, Inc.
MSSV
(Other OTC)

Recent

price

0.03

P/E

ratio

- -

div

yld

- -

ROIC.AI

2017
2018
2019
2020
2021
2022
2023
TTM
FRC
0.01
0.01
0.01
0.01
0.04
0.13
0.19
0.26
Revenue per Share
-0.11
-0.5
-0.47
-0.63
-1.12
-0.45
-0.79
-0.41
Basic EPS, GAAP
- -
-0.06
-0.07
-0.03
-0.86
-0.11
-0.06
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-6.73
-6.21
-5.26
-3.62
-4.06
-4.27
-4.98
-5.35
Book Value per Share
-0.74
-1.11
-1.39
-0.69
-1.13
-1.48
-1.91
-2.28
Tangible Book Value per Share
3
4
5
9
11
12
12
13
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
2
2
3
Sales/Revenue/Turnover
-1,712.12
-509.2
-5,285.55
-814.1
-2,265.32
-77.43
-29.68
-13.53
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
-2
-3
-6
-13
-6
-10
-5
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-1,289.31
-4,105.61
-8,335.2
-10,703.47
-2,942.42
-359.87
-407.21
-161.28
Profit Margin (%)
-3
-5
-7
-1
-1
-10
-22
-27
Working Capital
- -
- -
- -
6
12
8
2
2
LT Debt
-3
-5
-7
-6
-7
-12
-22
-27
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'24
Jun'24
Sep'24
ST Debt
16
17
17
LT Borrowings
2
2
2
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
12
12
13
Market Capitalization
1
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Mar'24
Jun'24
Sep'24
Total Current Assets
1
1
1
Cash, Cash Equivalents & STI
1
1
1
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
24
26
27
Payables & Accruals
8
9
10
ST Debt
16
17
17
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
42.77%
81.9%
Free Cash Flow
- -
574.05%
-38.69%
Net Income, GAAP
- -
59.28%
78.21%
Sales/Revenue/Turnover
- -
208.99%
57.49%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
1
2
2023
1
- -
1
1
2
2024
1
1
1
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
-0.14
-0.12
-0.11
- -
-0.45
2023
-0.13
-0.16
-0.47
- -
-0.79
2024
-0.16
-0.17
-0.07
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
Similar Companies
Mynews Holdings Bhd (5275.KL)
Emerge Commerce Ltd. (ECOM.V)
RSE Archive, LLC - Membership Interests Series - 86 Fleer 1986-87 Fleer Basketball Wax Box Fund (REAQS)
Abdullah Saad Mohammed Abo Moati for Bookstores Company (4191.SR)
Lloyds Luxuries Ltd. (LLOYDS.NS)
Bike24 Holding AG (BIKE.DE)
Business
Meso Numismatics, Inc. (MSSV) operates as a regenerative medicine company focused on the research, development, and distribution of cellular therapies and advanced medical products through its wholly owned subsidiary, Global Stem Cells Group; core offerings include mesenchymal stem cell treatments, exosome-based therapies, peptide lines for tissue regeneration, natural killer (NK) cell therapies, regenerative kits, specialized equipment for stem cell applications, lyophilized exosome products, patient procedures for tissue repair and aesthetic enhancements, clinical training programs via the International Society for Stem Cell Application (ISSCA), and global distribution of regenerative solutions to physicians treating injuries, chronic conditions, and degenerative diseases. Founded in 2015 and headquartered in Boca Raton, Florida, with previous addresses in Las Vegas, Nevada, and Miami, Florida, the company serves a global network of healthcare professionals across multiple regions, including expansions into medical tourism hubs like Dubai, emphasizing education through conferences, workshops, and certification programs alongside its biotechnology and healthcare segments. In a major strategic shift, Meso Numismatics changed its name to Regenerative Medical Technology Group, Inc. (RMTG) effective October 21, 2024, with FINRA approval on October 18, 2024, to reflect its full transition from numismatics to regenerative medicine leadership; recent activities encompass the launch of a revolutionary peptide line to enhance stem cell applications, ongoing clinical research collaborations, sponsorships such as Cellgenic's support for medical events, and clinic expansions supporting operational profitability in patient care, product supply, and training revenue streams.

Company News

APIChat

  • accesswire.com

    Meso Numismatics Changes Name to Regenerative Medical Technology Group and Ticker Symbol to RMTG

  • accesswire.com

    Meso Numismatics Announces Cellgenic's Sponsorship of Three Prominent Regenerative Medicine Events in Peru This September

  • globenewswire.com

    Meso Numismatics, a Renowned Leader in Regenerative Medical, Announces Global Stem Cells Groups (GSCG) Launch of Revolutionary New Line of Peptides

  • globenewswire.com

    Meso Numismatics Announces Intention to Undergo Name Change and Authorized Shares Change

  • globenewswire.com

    Meso Numismatics Increases 2023 Sales By 50% Year Over Year and Announces 2024 Forecast and Outlook

  • globenewswire.com

    Meso Numismatics Closes Global Stem Cell Group Acquisition

  • globenewswire.com

    Meso Numismatics and Global Stem Cell Group Enter Final Definitive Agreement

  • globenewswire.com

    Meso Numismatics Announces Final Post Closing Agreement

  • globenewswire.com

    Meso Numismatics Shareholder Update

  • globenewswire.com

    Meso Numismatics Eliminates All Convertible Debt In Renegotiation Deal and Files 10K